PeptideDB

SWE-101 2376322-12-0

SWE-101 2376322-12-0

CAS No.: 2376322-12-0

SWE101 (compound 22 b) is a potent soluble epoxide buffered enzyme (sEH)-P coupler with IC50s of 4 μM and 2.8 μM for t
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

SWE101 (compound 22 b) is a potent soluble epoxide buffered enzyme (sEH)-P coupler with IC50s of 4 μM and 2.8 μM for the dye sEH-P, respectively. SWE101 does not buffer the reagent sEH's buffering enzyme and phosphatase activities.

Physicochemical Properties


Molecular Formula C19H15CL2NO3
Molecular Weight 376.23
Exact Mass 375.042
CAS # 2376322-12-0
PubChem CID 139035063
Appearance White to off-white solid powder
Density 1.3±0.1 g/cm3
Boiling Point 533.3±50.0 °C at 760 mmHg
Flash Point 276.3±30.1 °C
Vapour Pressure 0.0±1.5 mmHg at 25°C
Index of Refraction 1.601
LogP 4.56
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 6
Heavy Atom Count 25
Complexity 444
Defined Atom Stereocenter Count 0
InChi Key UIADWSXPNFQQCZ-UHFFFAOYSA-N
InChi Code

InChI=1S/C19H15Cl2NO3/c20-14-10-9-13(11-15(14)21)18-19(12-5-2-1-3-6-12)25-16(22-18)7-4-8-17(23)24/h1-3,5-6,9-11H,4,7-8H2,(H,23,24)
Chemical Name

4-[4-(3,4-dichlorophenyl)-5-phenyl-1,3-oxazol-2-yl]butanoic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Discovery of first in vivo active inhibitors of soluble epoxide hydrolase (sEH) phosphatase domain. J Med Chem. 2019 Aug 22.


Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~265.79 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (6.64 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: 2.5 mg/mL (6.64 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (6.64 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.6579 mL 13.2897 mL 26.5795 mL
5 mM 0.5316 mL 2.6579 mL 5.3159 mL
10 mM 0.2658 mL 1.3290 mL 2.6579 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.